Antiviral Activity of a Selective Ribonucleotide Reductase Inhibitor against Acyclovir-Resistant Herpes Simplex Virus Type 1 In Vivo

Lignende værker

• Oral Bioavailability and In Vivo Efficacy of the Helicase-Primase Inhibitor BILS 45 BS against Acyclovir-Resistant Herpes Simplex Virus Type 1
  af: Duan, Jianmin, et al.
  Udgivet: (2003)
• Herpes Simplex Virus Ribonucleotide Reductase Mutants Are Hypersensitive to Acyclovir
  af: Coen, Donald M., et al.
  Udgivet: (1989)
• Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
  af: Coen, D M, et al.
  Udgivet: (1989)
• Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
  af: Spector, T, et al.
  Udgivet: (1992)
• Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.
  af: Safrin, S, et al.
  Udgivet: (1993)